financetom
Business
financetom
/
Business
/
--Palantir Technologies Q2 Government Revenue at $371 Million vs Visible Alpha Analyst Consensus of $348.2 Million; Commercial Revenue at $307 Million vs Consensus of $305.2 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Palantir Technologies Q2 Government Revenue at $371 Million vs Visible Alpha Analyst Consensus of $348.2 Million; Commercial Revenue at $307 Million vs Consensus of $305.2 Million
Aug 5, 2024 1:18 PM

04:13 PM EDT, 08/05/2024 (MT Newswires) --

Price: 28.42, Change: +4.32, Percent Change: +17.93

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mullen Buys Battery Line Equipment From Nikola
Mullen Buys Battery Line Equipment From Nikola
Jan 30, 2025
12:07 PM EST, 01/30/2025 (MT Newswires) -- Mullen Automotive ( MULN ) said Thursday it purchased additional battery line equipment from Nikola ( NKLA ) for its battery operations in Fullerton, California. Mullen said the recently purchased Nikola ( NKLA ) assets include a high-volume standard battery chemistry production line. The Fullerton facility produces battery packs, modules and advanced solid-state...
ServiceNow Delivered 'Solid' Q4 Results, But Were Short of Investors' 'High Expectations,' Oppenheimer Says
ServiceNow Delivered 'Solid' Q4 Results, But Were Short of Investors' 'High Expectations,' Oppenheimer Says
Jan 30, 2025
12:07 PM EST, 01/30/2025 (MT Newswires) -- ServiceNow ( NOW ) posted solid Q4 results driven by growth in subscription revenue with operating margin exceeding estimates but the results fell short of high investor expectations, Oppenheimer said in a note Thursday. The company's AI segment demonstrated traction as deals for the Now Assist product grew over 150% quarter-over-quarter while it...
Jupiter Neurosciences, Zina Biopharmaceuticals Collaborate on Phase 2a Parkinson's Disease Study
Jupiter Neurosciences, Zina Biopharmaceuticals Collaborate on Phase 2a Parkinson's Disease Study
Jan 30, 2025
12:07 PM EST, 01/30/2025 (MT Newswires) -- Jupiter Neurosciences ( JUNS ) said Thursday that it has entered into a partnership with Zina Biopharmaceuticals for an upcoming phase 2a clinical trial to evaluate Jupiter's Jotrol resveratrol-based platform in Parkinson's disease. Zina will assist with trial design, regulatory strategy, and trial site selection, according to Jupiter. The study has a primary...
What's Going On With FedEx Shares Thursday?
What's Going On With FedEx Shares Thursday?
Jan 30, 2025
FedEx Corporation ( FDX ) stock is trading lower on Thursday in sympathy with United Postal Service (UPS), which fell after it reported 2024 fiscal-year fourth-quarter earnings. UPS reported revenue of $25.30 billion, missing analysts estimate of $25.41 billion. In addition, the company reported adjusted earnings per share of $2.75, beating analysts estimate of $2.53. Additionally, UPS reported an operating...
Copyright 2023-2026 - www.financetom.com All Rights Reserved